According to a detailed industry analysis by Fact.MR, a market research and competitive intelligence provider, the global venous stents market is currently valued at US$ 1.08 billion and is projected to expand rapidly at a CAGR of 8.5% from 2022 to 2032.

Venous stents, which are metal mesh tubes, are used to treat chronic blood clots and other venous conditions. They provide a support structure to keep veins open, ensuring proper blood flow. Typically, surgeons implant venous stents in larger, major veins, such as those in the legs, chest, and abdomen

Get Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=7879

Venous stents are flexible tools that support the vascular walls in both peripheral and central veins. Key factors anticipated to boost the demand for venous stents during the projected period include the development of advanced technologies for accurate stent positioning and increased investments by key players in the advancement of flexible venous stents with enhanced radial strength.

North America currently dominates the global venous stents market, followed by Europe, which leads in sales due to a large pool of patients requiring venous stent implantation for various heart-related disorders. The presence of numerous top venous stent manufacturers and a developing healthcare industry further contribute to the market's growth in Europe.

Asia Pacific is quickly rising to prominence in the venous stents market, driven by increased investments in healthcare infrastructure and treatment standards across several countries in the region.

Key Takeaways from Market Study:

The global market for venous stent devices is projected to reach US$ 2.44 billion by 2032.
Germany’s market is predicted to expand at a CAGR of 7% during the forecast period.
Demand for venous stents in China is expected to rise at an impressive CAGR of 12% during the forecast period.
Revenue from Wallstent technologies is expected to increase at a high CAGR of 9% over the next 10 years.
“Sales of venous stents are set to more than double by the end of 2032,” says a Fact.MR analyst.

Leading providers in the venous stents market include Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical LLC, Gore Medical, Jotec GmbH, and OptiMed Medizinische Instrumente GmbH.

Country-wise Analysis:

The US currently leads the venous stent market in North America. This dominance is primarily due to the presence of major companies utilizing state-of-the-art medical technologies in the stent manufacturing process.

Additionally, a robust healthcare infrastructure and substantial government funding allocated to the healthcare industry are key factors propelling the growth of the venous stents market in the US. Favorable government regulations and an increase in research collaboration agreements also contribute to the potential rise in demand for venous stents.

The Centers for Disease Control and Prevention (CDC) reported in June 2022 that the United States could see 900,000 cases of deep vein thrombosis (DVT) or pulmonary embolism (PE) each year. Between one-third and fifty percent of patients with DVT may develop post-thrombotic syndrome, characterized by edema, discomfort, discoloration, and scaling in the affected limb. This high incidence underscores the growing need for effective venous stent solutions.

Read More: https://www.factmr.com/report/venous-stents-market

Competitive Landscape

Major venous stent companies are focused on launching upgraded stents and innovating technologies to accelerate sales growth.

Medtronic's venous stent, the "Abre Venous Self-Expanding Stent System," was approved by the US Food and Drug Administration (FDA) in October 2020. This device is recommended for treating symptomatic deep venous obstruction, also known as iliofemoral venous outflow obstruction.

In March 2022, Cordis received FDA approval for the "S.M.A.R.T. RADIANZ Vascular Stent System," a self-expanding stent specifically designed for radial peripheral operations. This system facilitates the accurate and effective insertion of stents in the superficial femoral (SFA) and iliac arteries, enhancing the precision and efficiency of these procedures.

Key Segments of Venous Stents Industry Research

By Application :
Leg
Chest
Abdomen
Arm
By Disease Indication :
Chronic Deep Vein Thrombosis
Post Thrombotic Syndrome
May-Thurner Syndrome
Hemodialysis/Arteriovenous Fistulae
By Technology :
Iliac Vein Stent Technologies
Wallstent Technologies
By Region :
North America
Latin America
Europe
East Asia
South Asia & Oceania
MEA
Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=7879

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: [email protected]